RT Journal Article
SR Electronic
T1 Chest wall hydatidosis: a case series of 26 patients
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 1699
DO 10.1183/13993003.congress-2020.1699
VO 56
IS suppl 64
A1 Saad, Asma
A1 Imen, Bouassida
A1 Abdelkbir, Amina
A1 Zribi, Hazem
A1 Ouerghui, Sonia
A1 Ayedi, Aida
A1 Adel, Marghli
YR 2020
UL http://erj.ersjournals.com/content/56/suppl_64/1699.abstract
AB Background: Hydatid cyst is an endemic disease that is common in the Mediterranean countries .Extra pulmonary intrathoracic localization of the cysts such as thoracic wall involving ribs, muscles, and vertebrae is very rareMethods: We retrospectively reviewed the records of 26 patients managed between 2000 and 2020 in the thoracic and cardiovascular surgery department of Abderrahmen Mami Hospital Ariana – Tunisia.Results: There were 9 woman and 17 men, with a mean age of 41 years (18-76).The most common signs were chest pain (12 cases), neurological deficit (5 cases) ,cough and dyspnea (3 cases). Parietal swelling was reported in 10 cases and 1 patient was asymptomatic. Chest X-ray showed an homogeneous opacity (6 cases), bone destruction (4 cases) and was normal in 5 cases. The cysts mostly were located at ribs (16 cases) and ribs with vertebrae (13 cases). Other parts of chest wall were involved like muscles and sub-cutaneous tissue in 1 case in the sternum in 2 cases. CT scan and MRI often revealed the diagnosis .The cyst was mimicking tumor in 1 case.15 patients underwent costal resection; 7 underwent a costovertebral resection. Other surgical procedures were partial resection of the sternum (two cases) and cystectomy with resection of parietal soft tissue (2 cases).the postoperative course was uneventful in 22 cases .reported complications were paraplegia in 1 case , ARDS and death in 1 case and severe sepsis in 2 cases. Albendazole was given for most cases.Conclusion: Current imaging investigations make diagnosis of chest wall hydatidosis easier. Radical surgery combined with antihelminthic therapy is the best treatment. Prevention is necessary.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 1699.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).